An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Stevanato Group (NYSE: STVN), a global provider of drug containment and delivery solutions, announced its participation in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21 and March 22, 2023. The company will present on March 21 at 11:15 a.m. ET, with a live audio webcast available on their website. A replay will be accessible for approximately 90 days post-event. Founded in 1949, Stevanato Group offers an integrated portfolio of products and services across the drug life cycle, emphasizing research, technical innovation, and engineering excellence.
Positive
None.
Negative
None.
PIOMBINO DESE, Italy--(BUSINESS WIRE)--
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum taking place on March 21 and March 22, 2023.
The Company will present on Tuesday, March 21, 2023 at 11:15 a.m. ET. A live audio webcast will be available on the Company’s website at www.stevanatogroup.com under the "Investors" section of the website. A replay will be available for approximately 90 days after the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.
When will Stevanato Group present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum?
Stevanato Group will present on March 21, 2023, at 11:15 a.m. ET.
How can I listen to the Stevanato Group presentation?
A live audio webcast of Stevanato Group's presentation will be available on their website under the 'Investors' section.
What dates is the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum?
The forum takes place on March 21 and March 22, 2023.
How long will the replay of Stevanato Group's presentation be available?
The replay will be available for approximately 90 days after the event.
What does Stevanato Group specialize in?
Stevanato Group specializes in drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries.
